Difficulty: Medium
Average Score: 86%
Practice
Best drug for use against the meningococcal carrier state is
Correct answer
D
Rationale
In the context of treating the meningococcal carrier state, the best drug among the options provided is Rifampin (Option D). Rifampin is effective against Neisseria meningitidis, the bacterium responsible for meningococcal disease. It is commonly used in prophylaxis to eliminate the carrier state and prevent the spread of the bacteria to others.
Ethionamide (Option A) is primarily used in the treatment of tuberculosis, not for meningococcal infections. Kanamycin (Option B) is an aminoglycoside antibiotic mainly used for severe bacterial infections but is not the first-line choice for treating meningococcal carrier state. Ethambutol (Option C) is used in tuberculosis treatment and is not effective against Neisseria meningitidis.
Educationally, understanding the specific indications of antibiotics is crucial for effective treatment. In the case of meningococcal carrier state, selecting the appropriate antibiotic like Rifampin is essential to prevent transmission of the pathogen. This rationale highlights the importance of matching the drug's spectrum of activity with the specific pathogen causing the infection, which is a fundamental concept in antimicrobial therapy.
Ethionamide (Option A) is primarily used in the treatment of tuberculosis, not for meningococcal infections. Kanamycin (Option B) is an aminoglycoside antibiotic mainly used for severe bacterial infections but is not the first-line choice for treating meningococcal carrier state. Ethambutol (Option C) is used in tuberculosis treatment and is not effective against Neisseria meningitidis.
Educationally, understanding the specific indications of antibiotics is crucial for effective treatment. In the case of meningococcal carrier state, selecting the appropriate antibiotic like Rifampin is essential to prevent transmission of the pathogen. This rationale highlights the importance of matching the drug's spectrum of activity with the specific pathogen causing the infection, which is a fundamental concept in antimicrobial therapy.